Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies

American Journal of Hematology

Volumn 58, Issue 4, 1998, Pages 255-262

  D'Arena, Giovanni ^a   Musto, Pellegrino ^a   Di Mauro, Lazzaro ^a   Cascavilla, Nicola ^a   Dello Iacono, Nicola ^a   Scalzulli, Potito Rosario ^a   Matera, Rosella ^a   Carotenuto, Mario ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

CD34+ peripheral blood progenitor cells; Flow cytometry; Leukapheresis; Mobilizing therapy; Monocyte count; White blood cell count

Indexed keywords

CARMUSTINE; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDARUBICIN; MITOXANTRONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MONOCYTE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; CELL COUNT; CHILD; CHILD, PRESCHOOL; COLONY-FORMING UNITS ASSAY; GRANULOCYTES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; LINEAR MODELS; MACROPHAGES; MIDDLE AGED; MONOCYTES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0031815433     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199808)58:4<255::AID-AJH1>3.0.CO;2-P     Document Type: Article

References (33)

1. Richman CM, Weiner RS, Yankee RA: Increase in circulating stem cells following chemotherapy in man. Blood 47:1031, 1976.
2. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni M: Circulating of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74:1905, 1989.
3. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G: Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet 2:508, 1989.
4. Peters WP, Rosner G, Ross M, Vredenbirgh J, Meisenberg B, Gilbert C, Kurtzberg J: Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 81:1709, 1993.
5. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM: Flow cytometry for clinical estimation of circulating hematopoietic progenitor for autologous transplantation in cancer patients. Blood 77:400, 1991.
6. D'Arena G, Scalzulli P, Musto P: Circulating hematopoietic progenitor cells in leukapheresis: Flow cytometric estimation. Haematologica 81: 95, 1996.
7. Berenson RJ, Bensinger WI, Hill RS, Andrews RG, Garcia-Lopez J, Kalamsz DF, Still BJ, Spitzer G, Buckner DC, Bernstein ID, Thomas ED: Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991.
8. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD: Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following ablative therapy. Blood 71: 723, 1988.
9. Williams SF, Bitran JD, Richards JM, DeCristopher PJ, Barker E, Conant J, Golomb HM, Orlina AR: Peripheral blood-derived stem cell collections for use in autologous transplantation after high-dose chemotherapy: An alternative approach. Bone Marrow Transplant 5:129, 1990.
10. To LB, Roberts MM, Haylock DN, Dyson PG, Brandford AL, Thorp D, Ho JQK, Dart GW, Norvath N, Davy MLJ, Olweny CLM, Abdi E, Juttner CA: Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277, 1992.
11. Kotasek D, Shepherd KM, Sage RE, Dale BM, Norman JE, Charles P, Grigg A, Pillow A, Bolton A: Factors affecting blood stem cell collections after high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 9:11, 1992.
12. Hansson M, Svensson A, Engervall P, Bjorkhol M, Gruber A, Soderstrom T: Increase of monocytes predicts mobilization of peripheral stem and progenitor cells after chemotherapy followed by G-CSF administration. Eur J Haematol 54:321, 1995.
13. Cagnoni PJ, Shpall EJ: Mobilization and selection of CD34-positive hematopoietic progenitors. Blood Rev 10:1, 1996.
14. Siena S, Bregni M, Gianni AM: Estimation of peripheral blood CD34+ cells for autologous transplantation in cancer patients. Exp Hematol 21:203, 1993.
15. Leibundgut K, von Rohr A, Brulhart K, Hirt A, Ischi E, Jeanneret C, Muff J, Ridolfi-Luthy A, Wagner HP, Tobler A: The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children. Bone Marrow Transplant 15:25, 1995.
16. Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y, Steenssens L, van Camp B, De Waele M: The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 17:509, 1996.
17. Elliott B, Samson DM, Armitage S, Lyttelton MP, McGuidan D, Hargreaves R, Giles C, Abrahamson G, Abboudi Z, Brennan M, Kanfer EJ: When to harvest peripheral-blood stem cells after mobilization therapy: Prediction of CD34-positive cell yield preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 14:970, 1996.
18. Siena S, Bregni M, Belli N, Ravagnani F, Notti P, Magni M, Di Nicola M, Bonadonna G, Gianni AM: Practical aspects of flow cytometry to guide large-scale collection of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Intern J Cell Cloning 10(Suppl 1):26, 1992.
19. Siena S, Bregni M, Di Nicola M, Peccatori F, Magni M, Brando B, Ravagnani F, Gianni AM: Milan protocol for clinical CD34+ cell estimation in peripheral blood for autografting in patients with cancer. In Hematopoietic Stem Cells: The Mulhouse Manual. Dayton, OH: AlphaMed Press, 1994, p 23.
20. D'Arena G, Cascavilla N, Musto P, Greco M, Di Mauro L, Carella AM, Dello Iacono N, Carotenuto M: Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients. Haematologica 81:216, 1996.
21. Gordon MY, Blackett NM: Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplant 15:659, 1995.
22. Gianni AM: Where do we stand with respect to the use of peripheral blood progenitor cells? Ann Oncol 5:781, 1994.
23. Siena S, Bregni M, Di Nicola M, Ravignani F, Peccatori F, Gandola C, Lombardi F, Tarella C, Bonadonna G, Gianni AM: Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann Oncol 5:935, 1994.
24. D'Arena G, Musto P, Carotenuto M: When to perform peripheral blood progenitor cell collection in hematological patients? Haematologica 82:124, 1997.
25. Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787, 1994.
26. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner D: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547, 1995.
27. Demirer T, Buckner CD, Gooley T, Appelbaum F, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger WI: Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 17:937, 1996.
28. Carella AM, Podesta' M, Frassoni F, Raffo MR, Pollicardo N, Pungolino E, Vimercati R, Sassarego M, Parodi C, Rabitti C, Ferrero R, Benvenuto F, Figari O, Carlier P, Levcasic G, Valbonesi M, Vitale V, Giordano D, Pierluigi D, Nati S, Guerraçio A, Rosso C, Saglio G: Collection of normal blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 12:267, 1993.
29. Gazitt Y, Reading CC, Hoffman R, Wickrema A, Vesole DH, Jagannath S, Condino J, Lee B, Barlogie B, Tricot G: Purified CD34 + Lin-Thy-1+ stem cells do not contain clonal myeloma cells. Blood 86:381, 1995.
30. Frassoni F, Carella AM: Collection, analysis and transplantation of Ph-negative blood precursor cells in chronic myeloid leukemia. Leukemia 10(Suppl 2):30, 1996.
31. Gazitt Y, Tian E, Barlogie B, Reading CL, Vesole DH, Jagannath S, Schnell J, Hoffman R, Tricot G: Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 87:805, 1996.
32. Caligaris Cappio F, Cavo M, De Vincentiis A, Lanuta L, Lemoli RM, Majolino I, Tarella C, Zanon P, Tura S: Peripheral blood stem cell transplantation for the treatment of multiple myeloma: Biological and clinical implications. Haematologica 81:356, 1996.
33. Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C: CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 20:587, 1997.